Mettler-Toledo International - MTD Stock Forecast, Price & News

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Mettler-Toledo International in the last year. There are currently 4 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" MTD shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MTD, but not buy additional shares or sell existing shares.
View MTD analyst ratings or view top-rated stocks.

6 brokers have issued 12 month price targets for Mettler-Toledo International's shares. Their MTD share price forecasts range from $1,237.00 to $1,650.00. On average, they expect the company's stock price to reach $1,396.00 in the next year. This suggests that the stock has a possible downside of 12.3%.
View analysts price targets for MTD or view top-rated stocks among Wall Street analysts.

Mettler-Toledo International's stock was trading at $1,445.45 on January 1st, 2023. Since then, MTD stock has increased by 10.1% and is now trading at $1,591.65.
View the best growth stocks for 2023 here.

Mettler-Toledo International saw a increase in short interest in January. As of January 15th, there was short interest totaling 320,800 shares, an increase of 15.2% from the December 31st total of 278,400 shares. Based on an average daily trading volume, of 100,200 shares, the short-interest ratio is presently 3.2 days. Currently, 1.5% of the shares of the stock are sold short.
View Mettler-Toledo International's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Friday, February 10th 2023.
View our MTD earnings forecast.

Mettler-Toledo International will be holding an earnings conference call on Friday, February 10th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.

Mettler-Toledo International Inc. (NYSE:MTD) released its earnings results on Thursday, November, 4th. The medical instruments supplier reported $8.72 EPS for the quarter, beating the consensus estimate of $8.28 by $0.44. The medical instruments supplier had revenue of $951.95 million for the quarter, compared to analyst estimates of $931.63 million. Mettler-Toledo International had a net margin of 21.48% and a trailing twelve-month return on equity of 1,929.28%. The firm's quarterly revenue was up 17.9% compared to the same quarter last year. During the same period last year, the business earned $7.02 EPS.
Read the conference call transcript.

Mettler-Toledo International issued an update on its fourth quarter 2022 earnings guidance on Thursday, November, 10th. The company provided EPS guidance of $11.55-$11.65 for the period, compared to the consensus EPS estimate of $11.87. The company issued revenue guidance of $1.11 billion-$1.11 billion, compared to the consensus revenue estimate of $1.06 billion.

224 employees have rated Mettler-Toledo International Chief Executive Officer Olivier A. Filliol on Glassdoor.com. Olivier A. Filliol has an approval rating of 88% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Mettler-Toledo International investors own include Intuitive Surgical (ISRG), NVIDIA (NVDA), Home Depot (HD), Adobe (ADBE), AbbVie (ABBV), Johnson & Johnson (JNJ), Northrop Grumman (NOC), Alibaba Group (BABA), Lockheed Martin (LMT) and Broadcom (AVGO).

Mettler-Toledo International trades on the New York Stock Exchange (NYSE) under the ticker symbol "MTD."

Mettler-Toledo International's stock is owned by many different institutional and retail investors. Top institutional investors include Baillie Gifford & Co. (1.46%), Congress Asset Management Co. MA (0.42%), Sumitomo Mitsui Trust Holdings Inc. (0.40%), Welch & Forbes LLC (0.30%), AustralianSuper Pty Ltd (0.26%) and New York State Common Retirement Fund (0.26%). Insiders that own company stock include Christian Magloth, Elisha W Finney, Gerry Keller, La Guerroniere Marc De, Oliver A Filliol, Olivier A Filliol, Patrick Kaltenbach, Peter Aggersbjerg, Robert F Spoerry, Robert F Spoerry, Shawn Vadala, Thomas P Salice and Wah-Hui Chu.
View institutional ownership trends.

Shares of MTD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of MTD stock can currently be purchased for approximately $1,591.65.

Mettler-Toledo International (NYSE:MTD) has a market capitalization of $35.48 billion and generates $3.72 billion in revenue each year. The medical instruments supplier earns $768.98 million in net income (profit) each year or $36.54 on an earnings per share basis.

The company employs 17,800 workers across the globe.

Mettler-Toledo International's mailing address is 1900 POLARIS PARKWAY, COLUMBUS OH, 43240. The official website for the company is www.mt.com. The medical instruments supplier can be reached via phone at (614) 438-4748, via email at mary.finnegan@mt.com, or via fax at 614-438-4900.